MORGAN STANLEY - Significant Ownership

Signature - Title
Chris O'Hara - Authorized Signatory
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by MORGAN STANLEY.

Significant Ownership of MORGAN STANLEY

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
KTCC KEY TRONIC CORP Common Stock 16% $6.65M 1.73M Morgan Stanley Dec 31, 2024
WEA WESTERN ASSET PREMIER BOND FUND Common Shares of Beneficial Interest 13% $16.7M 1.54M Morgan Stanley Dec 31, 2024
BMN BlackRock 2037 Municipal Target Term Trust Common Shares of Beneficial Interest 11.8% $18.2M 727K Morgan Stanley Dec 31, 2024
ABUS Arbutus Biopharma Corp Common Shares 11.4% $71.2M 21.5M Morgan Stanley Dec 31, 2024
AUR Aurora Innovation, Inc. Class A Common Stock 10.1% $881M $110M 141M +14.3% Morgan Stanley Mar 31, 2025
LB LandBridge Co LLC Class A Shares 10% $161M 2.33M Morgan Stanley Feb 28, 2025
GBAB Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust Common Shares of Beneficial Interest 9.6% $37.3M 2.38M Morgan Stanley Dec 31, 2024
TYG TORTOISE ENERGY INFRASTRUCTURE CORP Common Stock 8.9% $39M 961K Morgan Stanley Dec 31, 2024
OPP RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. Common Stock 8.7% $17.4M 2M Morgan Stanley Dec 31, 2024
BGY BlackRock Enhanced International Dividend Trust Common Stock 8.6% $46.4M 8.24M Morgan Stanley Dec 31, 2024
TSHA Taysha Gene Therapies, Inc. Common Stock 8.6% $30.3M 17.6M Morgan Stanley Dec 31, 2024
NPCE NeuroPace Inc Common Stock 8.3% $27.3M 2.49M Morgan Stanley Dec 31, 2024
NVST Envista Holdings Corp Common Stock 8.2% $237M 14.1M Morgan Stanley Dec 31, 2024
AFRM Affirm Holdings, Inc. Class A Common Stock 8.1% $1.15B 22.1M Morgan Stanley Dec 31, 2024
GLQ Clough Global Equity Fund Common Stock 7.9% $10.2M 1.48M Morgan Stanley Dec 31, 2024
APLS Apellis Pharmaceuticals, Inc. Common Stock 7.7% $241M 9.59M Morgan Stanley Dec 31, 2024
IOT Samsara Inc. Class A Common Stock 7.6% $780M 20.5M Morgan Stanley Dec 31, 2024
KRNT Kornit Digital Ltd. Ordinary Shares 7.5% $75.9M 3.56M Morgan Stanley Dec 31, 2024
LUNG Pulmonx Corp Common Stock 7.5% $22.1M 2.97M Morgan Stanley Dec 31, 2024
GUG Guggenheim Active Allocation Fund Common Shares 7.3% $37.1M 2.41M Morgan Stanley Dec 31, 2024
NPCT NUVEEN CORE PLUS IMPACT FUND Common Shares of Beneficial Interest 7.3% $22.9M 2.11M Morgan Stanley Dec 31, 2024
MUE BLACKROCK MUNIHOLDINGS QUALITY FUND II, INC. Common Shares 7.1% $15.9M 1.56M Morgan Stanley Dec 31, 2024
GAXY GALAXY NEXT GENERATION, INC. Common Stock 6.9% $48.4K 4.84M Morgan Stanley Dec 31, 2024
LSAK LESAKA TECHNOLOGIES INC Common Stock 6.6% $24.6M 5.21M Morgan Stanley Dec 31, 2024
EMO ClearBridge Energy Midstream Opportunity Fund Inc. Common Stock 6.5% $55.3M 1.18M Morgan Stanley Dec 31, 2024
STOK Stoke Therapeutics, Inc. Common Stock 6.5% $29.2M 3.43M Morgan Stanley Dec 31, 2024
SNDX Syndax Pharmaceuticals Inc Common Stock 6.3% $67.2M 5.36M Morgan Stanley Dec 31, 2024
PRAX Praxis Precision Medicines, Inc. Common Stock 6.2% $44.6M 1.16M Morgan Stanley Dec 31, 2024
CYH COMMUNITY HEALTH SYSTEMS INC Common Stock 6.2% $25.4M 8.65M Morgan Stanley Dec 31, 2024
BYON BEYOND, INC. Common Stock 6.1% $14M 2.79M Morgan Stanley Dec 31, 2024
USPH U S PHYSICAL THERAPY INC /NV Common Stock 5.9% $68.5M 890K Morgan Stanley Dec 31, 2024
COUR Coursera, Inc. Common Stock 5.9% $65.4M 9.35M Morgan Stanley Dec 31, 2024
RDWR RADWARE LTD Ordinary Shares 5.9% $58.4M 2.48M Morgan Stanley Dec 31, 2024
JKHY JACK HENRY & ASSOCIATES INC Common Stock 5.8% $745M 4.25M Morgan Stanley Dec 31, 2024
TAL TAL Education Group Class A Common Shares 5.8% $117M 8.91M Morgan Stanley Dec 31, 2024
HIO WESTERN ASSET HIGH INCOME OPPORTUNITY FUND INC. Common Shares of Beneficial Interest 5.8% $22.4M 5.48M Morgan Stanley Dec 31, 2024
TBBB BBB FOODS INC Class A Common Shares 5.6% $54.9M 2.18M Morgan Stanley Dec 31, 2024
RERE ATRenew Inc. Class A Ordinary Shares 5.6% $16.3M 4.89M Morgan Stanley Dec 31, 2024
GLO Clough Global Opportunities Fund Common Shares of Beneficial Interest 5.6% $12M 2.41M Morgan Stanley Dec 31, 2024
TPB Turning Point Brands, Inc Common Stock 5.4% $54.2M 952K Morgan Stanley Dec 31, 2024
CCCC C4 Therapeutics, Inc. Common Stock 5.4% $9.11M 3.83M Morgan Stanley Dec 31, 2024
AXGN Axogen, Inc. Common Stock 5.3% $40.7M 2.33M Morgan Stanley Dec 31, 2024
EMD WESTERN ASSET EMERGING MARKETS DEBT FUND INC. Common Stock 5.3% $30.4M 3.1M Morgan Stanley Dec 31, 2024
EAD ALLSPRING INCOME OPPORTUNITIES FUND Common Shares 5.1% $20.7M 3.03M Morgan Stanley Dec 31, 2024
Theratechnologies Inc. Common Shares 5% 2.31M Morgan Stanley Dec 31, 2024
JRI Nuveen Real Asset Income & Growth Fund Common Stock 4.9% $17.2M 1.34M Morgan Stanley Dec 31, 2024
DASH DoorDash, Inc. Class A Common Stock 4.8% $3.35B 18.8M Morgan Stanley Dec 31, 2024
SDHY PGIM Short Duration High Yield Opportunities Fund Common Shares 4.7% $19.3M 1.15M Morgan Stanley Dec 31, 2024
ASGI abrdn Global Infrastructure Income Fund Common Shares of Beneficial Interest 4.5% $23.8M 1.31M Morgan Stanley Dec 31, 2024
SPHR Sphere Entertainment Co. Class A Common Stock 4.4% $45M 1.27M Morgan Stanley Dec 31, 2024
RA Brookfield Real Assets Income Fund Inc. Common Stock 4.4% $32.6M 2.46M Morgan Stanley Dec 31, 2024
WIW WESTERN ASSET INFLATION-LINKED OPPORTUNITIES & INCOME FUND Common Shares of Beneficial Interest 4.1% $20.8M 2.49M Morgan Stanley Dec 31, 2024
RLTY Cohen & Steers Real Estate Opportunities & Income Fund Common Shares 4.1% $10.3M 680K Morgan Stanley Dec 31, 2024
PTON PELOTON INTERACTIVE, INC. Class A Common Stock 3.9% $82.9M 14.4M Morgan Stanley Mar 31, 2025
FINS Angel Oak Financial Strategies Income Term Trust Common Shares of Beneficial Interest 3.5% $11.8M 877K MORGAN STANLEY Jan 7, 2025
TMCI TREACE MEDICAL CONCEPTS, INC. Common Stock 3.4% $17.3M 2.09M Morgan Stanley Dec 31, 2024
RCMT RCM TECHNOLOGIES INC Common Stock 3% $4.54M 227K Morgan Stanley Dec 31, 2024
ZTR Virtus Total Return Fund Inc. Common Shares 2.7% $9.66M 1.67M Morgan Stanley Dec 31, 2024
NPFD Nuveen Variable Rate Preferred & Income Fund Common Shares of Beneficial Interest 2.5% $11.2M 594K Morgan Stanley Dec 31, 2024
APLT Applied Therapeutics, Inc. Common Stock 2.5% $1.43M 2.86M Morgan Stanley Jan 31, 2025
ETWO E2open Parent Holdings, Inc. Class A Common Stock 2.4% $16.5M 7.47M Morgan Stanley Dec 31, 2024
BILL BILL Holdings, Inc. Common Stock 1.9% $88.3M 1.92M MORGAN STANLEY Dec 31, 2024
URGN UroGen Pharma Ltd. Ordinary Shares 1.8% $8.15M 753K Morgan Stanley Dec 31, 2024
SAGE Sage Therapeutics, Inc. Common Stock 1.6% $7.49M -$26.1M 1.01M -77.7% Morgan Stanley Feb 28, 2025
PHAR Pharming Group N.V. Ordinary Shares / American Depositary Shares 1.2% $77.2M 8.47M Morgan Stanley Mar 31, 2025
NLOP Net Lease Office Properties Common Shares of Beneficial Interest 0.9% $4.49M 138K Morgan Stanley Feb 28, 2025
PLYA Playa Hotels & Resorts N.V. Ordinary Shares 0.3% $5.38M 404K Morgan Stanley Mar 31, 2025
CMAX CareMax, Inc. Class A Common Stock 0.1% $1.3K 3.03K MORGAN STANLEY Dec 31, 2024
FUFU Bitfufu Inc. Class A Ordinary Shares 0% $2.86K 638 MORGAN STANLEY Dec 31, 2024
MRNS MARINUS PHARMACEUTICALS, INC. COMMON STOCK 0% $0 -$1.81M 0 -100% Morgan Stanley Feb 28, 2025
IHTA Invesco High Income 2024 Target Term Fund Common Stock 0% $0 0 MORGAN STANLEY Dec 31, 2024
NTG Tortoise Midstream Energy Fund, Inc. Common Stock 0% $0 0 MORGAN STANLEY Dec 31, 2024

Schedules 13D/G Reported by MORGAN STANLEY:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.